Screener
BioCryst Pharmaceuticals BCRX Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other non-program specific and indirect costs | 7,044 | 6,743 | 14,463 | 13,289 |
| Sales and marketing (excluding stock-based compensation) | 33,947 | 45,589 | 76,900 | 93,259 |
| General and administrative (excluding stock-based compensation) | 20,810 | 29,817 | 63,203 | 51,776 |
| Stock-based compensation | 14,692 | 21,304 | 30,719 | 42,672 |
| Interest income | (2,434) | (2,516) | (4,690) | (5,540) |
| Interest expense | 21,712 | 21,582 | 41,491 | 45,076 |
| Foreign currency (gains) losses | (27) | 63 | 198 | 62 |
| Loss on extinguishment of debt | — | 4,171 | — | 4,171 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's stock-based comp?
- BioCryst Pharmaceuticals (BCRX) reported stock-based comp of $14.69M in Q2 2026.
- How has BioCryst Pharmaceuticals's stock-based comp changed year-over-year?
- BioCryst Pharmaceuticals's stock-based comp decreased by 31.0% year-over-year, from $21.3M to $14.69M.
- What is the long-term trend for BioCryst Pharmaceuticals's stock-based comp?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's stock-based comp has grown at a 25.2% compound annual growth rate (CAGR), from $34.64M to $85.07M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about BioCryst Pharmaceuticals's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude